Monday, December 17, 2012

Data Technical News #2012 - 39
Accelr8 Corporation to Begin Listing on NASDAQ as Accelerate Diagnostics, Inc on Wednesday, December 26, 2012

Markets Impacted:

Products Impacted:

  • All NASDAQ and UTP Data Feeds

Contact Information:

What you need to know:

  • On Wednesday, December 26, 2012, Accelr8 Corporation (NYSE MKT: AXK) will begin trading on the NASDAQ Capital Market®.
  • Additionally, on Wednesday, December 26, 2012, Accelr8 Corporation will change its name to Accelerate Diagnostics, Inc.
  • Accelerate Diagnostics, Inc will be listed on NASDAQ under the new ticker symbol "AXDX".
  • The company will continue to be traded on NYSE through Monday, December 24, 2012.

What is changing?

On Wednesday, December 26, 2012, Accelr8 Corporation (NYSE MKT: AXK) will begin trading on the NASDAQ Capital Market as Accelerate Diagnostics, Inc. Accelerate Diagnostics stock will be listed on NASDAQ under the ticker symbol "AXDX". The company will continue to be traded on NYSE MKT through Monday, December 24, 2012.

Accelerate Diagnostics is focused on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The Company's BACcelTM platform utilizes a proprietary culture-free process with both genomic and phenotypic detection technologies that decrease time to result while maintaining high sensitivity and specificity. Learn more at www.accelr8.com

What are the issue details for the new NASDAQ listing?

The issue mapping for Accelerate Diagnostics is as follows:

Issue Name CUSIP NYSE/ CQS Ticker through December 24, 2012 NASDAQ Ticker as of December 26, 2012 NASDAQ Market Category Round Lot Size
Accelerate Diagnostics, Inc. 004304200 AXK AXDX NASDAQ Capital Market 100

What database changes do NASDAQ market data redistributors need to make to accommodate the new listing?

NASDAQ® asks that all market data redistributors update their database to reflect the new listing market for Accelerate Diagnostics on Wednesday, December 26, 2012. NASDAQ requests that market data redistributors retain historical data from NYSE MKT for AXK.

When the issue moves from NYSE MKT to NASDAQ, firms will see a change in the consolidated data source for Accelerate Diagnostics. Please note that the consolidated market data for all NASDAQ-listed issues is disseminated via the UTP Quotation Data FeedSM (UQDFSM) and UTP Trade Data FeedSM (UTDFSM). Firms will begin to see quotation and trade data for Accelerate Diagnostics on UQDF and UTDF beginning in the pre-market trading hours on Wednesday, December 26, 2012.

For firms that report end usage numbers by the query, NASDAQ reminds them that the Level 1, NASDAQ Basic and NASDAQ Last Sale (NLS) counts should include quote and trade queries for Accelerate Diagnostics (AXDX) beginning on Wednesday, December 26, 2012.

Contact Information

If you have questions about Accelerate Diagnostics , please contact:

If you would like to register as a market maker in AXDX, please contact:



Email Alert Subscriptions:
Nasdaq offers customers the ability to self select news delivery across various Nasdaq markets. Create and maintain a profile for updating alert preferences and contact information. Visit the enrollment form on the Nasdaq Trader website and sign up today! Please note that if you choose to unsubscribe from an email list, you may no longer receive potentially critical emails from the NASDAQ Stock Market regarding Nasdaq's trading and data products, regulatory issues or marketplace initiatives. To unsubscribe, also click on the enrollment form

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.